Skip to content

NRSN

NeuroSense Therapeutics Ltd.

NASDAQ · Healthcare · Biotechnology · IL

$0.50
+23.28%
Ask drillr
2
Insider buys (3m)
0
Insider sells (3m)
$400.0K
Net value (3m)
-36.0%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jun 17, 2026Eisenberg Or · officer: Chief Financial OfficerPurchase250,000$0.80
Jun 17, 2026Ben-Noon Alon · officer: Chief Executive OfficerPurchase250,000$0.80
Mar 30, 2026Russek-Blum Niva · officer: Chief Technology OfficerA-Award200,000$0.00
Mar 30, 2026Binder Hagit · officer: General ManagerA-Award200,000$0.00
Institutional positioning

13F filings over the trailing two quarters

New 3Increased 1Reduced 3Sold out 13
FilerActionSharesFiled
YORKVILLE ADVISORS GLOBAL, LPReduced78,000May 13, 2026
INDEPENDENT ADVISOR ALLIANCENew Position50,000May 12, 2026
UBS GROUP AGIncreased49,096May 5, 2026
TWO SIGMA INVESTMENTS, LPReduced44,445May 15, 2026
MEITAV INVESTMENT HOUSE LTDUnchanged40,000Apr 29, 2026
JANE STREET GROUP, LLCNew Position28,670May 12, 2026
COMMONWEALTH EQUITY SERVICES, LLCUnchanged22,775Apr 27, 2026
PNC FINANCIAL SERVICES GROUP, INC.New Position21,150May 8, 2026
PATHSTONE HOLDINGS, LLCUnchanged16,528May 11, 2026
GEODE CAPITAL MANAGEMENT, LLCUnchanged15,870May 15, 2026
CREATIVE PLANNINGUnchanged11,911May 12, 2026
JONES FINANCIAL COMPANIES LLLPUnchanged1,000May 15, 2026
SBI SECURITIES CO., LTD.Reduced265Apr 28, 2026
Pathstone Holdings, LLCSold Out0May 11, 2026
SBI Securities Co., Ltd.Sold Out0Apr 28, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 17, 2026